A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Name: A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
License: Public Domain

BioNTech SE

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

unresectable head and neck squamous cell carcinoma, metastatic head and neck cancer, recurrent head and neck cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152501
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.